Authors:
HOUBEN AJHM
KROON AA
DEHAAN CHA
FUSSLEJEUNE M
DELEEUW PW
Citation: Ajhm. Houben et al., THE EFFECTS OF LOCAL QUINAPRILAT ENALAPRILAT INFUSION ON FOREARM BLOOD-FLOW IN ESSENTIAL-HYPERTENSION/, Journal of vascular research, 35, 1998, pp. 35-35
Authors:
SPIERING W
KROON AA
FUSSLEJEUNE MJMJ
DAEMEN MJAP
DELEEUW PW
Citation: W. Spiering et al., ALTERED PHENOTYPE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN NORMO-TENSIVE AND HYPERTENSIVE PATIENTS GENOTYPED FOR THE ANGIOTENSIN-II TYPE-1 RECEPTOR POLYMORPHISM, Journal of hypertension, 16, 1998, pp. 404-404
Authors:
WIEREMA TKA
HOUBEN AJHM
POSTMA CT
THIEN T
KROON AA
DELEEUW PW
Citation: Tka. Wierema et al., ADENOSINE INDUCES VASODILATION IN THE HUMAN HYPERTENSIVE KIDNEY - COMPETITIVE-INHIBITION BY CAFFEINE, Journal of hypertension, 16, 1998, pp. 2417-2417
Authors:
POSTMA CT
WIEREMA TKA
HOUBEN AJHM
KROON AA
THIEN T
DELEEUW PW
Citation: Ct. Postma et al., ADENOSINE-INDUCED RENAL VASODILATATION IS PROLONGED IN RENAL-ARTERY STENOSIS - COMPARISON WITH ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 2423-2423
Authors:
RODRIGUEZ SA
KROON AA
ATKINS N
OWENS P
LEEUW PW
OBRIEN ET
Citation: Sa. Rodriguez et al., VALUE OF AMBULATORY BLOOD-PRESSURE MONITORING TO ASCERTAIN TREATMENT-RESISTANT HYPERTENSION, Journal of hypertension, 16, 1998, pp. 3515-3515
Authors:
RODRIGUEZ SA
KROON AA
LYONS S
OWENS P
DELEEUW PW
OBRIEN ET
Citation: Sa. Rodriguez et al., FAMILY HISTORY OF HYPERTENSION IS NOT ASSOCIATED WITH INCREASED BLOOD-PRESSURE VARIABILITY, Journal of hypertension, 16, 1998, pp. 3531-3531
Authors:
HOUBEN AJHM
KROON AA
FUSSLEJEUNE MJMJ
DEHAAN CHA
DELEEUW PW
Citation: Ajhm. Houben et al., EFFECTS OF QUINAPRILAT VERSUS ENALAPRILAT ON FOREARM BLOOD-FLOW IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 31058-31058
Authors:
SPIERING W
KROON AA
FUSSLEJEUNE MJMJ
DAEMEN MJAP
DELEEUW PW
Citation: W. Spiering et al., ALTERED PHENOTYPE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) IN HYPERTENSIVE PATIENTS GENOTYPED FOR THE ANGIOTENSIN-II TYPE-1 RECEPTOR (AT1R) POLYMORPHISM, Hypertension, 32(4), 1998, pp. 304-304
Citation: Pw. Deleeuw et Aa. Kroon, WHAT GOES UP, MUST COME DOWN - TREATING THE HYPERTENSIVE EMERGENCY, European Journal of Clinical Pharmacology, 54(4), 1998, pp. 277-279
Citation: Aa. Kroon et Afh. Stalenhoef, LDL-CHOLESTEROL LOWERING AND ATHEROSCLEROSIS - CLINICAL BENEFIT AND POSSIBLE MECHANISMS - AN UPDATE, Netherlands journal of medicine, 51(1), 1997, pp. 16-27
Citation: Pw. Deleeuw et Aa. Kroon, FIXED LOW-DOSE COMBINATION OF AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR AND A CALCIUM-CHANNEL BLOCKER DRUG IN THE TREATMENT OF ESSENTIAL-HYPERTENSION, Journal of hypertension, 15, 1997, pp. 39-42
Authors:
AENGEVAEREN WRM
KROON AA
STALENHOEF AFH
UIJEN GJH
VANDERWERF T
Citation: Wrm. Aengevaeren et al., LOW-DENSITY-LIPOPROTEIN APHERESIS IMPROVES REGIONAL MYOCARDIAL PERFUSION IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND EXTENSIVE CORONARY-ARTERY DISEASE - THE LDL-APHERESIS ATHEROSCLEROSIS REGRESSION STUDY (LAARS), Journal of the American College of Cardiology, 28(7), 1996, pp. 1696-1704
Citation: Aa. Kroon et al., LISSENCEPHALY WITH EXTREME CEREBRAL AND CEREBELLAR HYPOPLASIA - A MAGNETIC-RESONANCE-IMAGING STUDY, Neuropediatrics, 27(5), 1996, pp. 273-276
Authors:
KROON AA
AENGEVAEREN WRM
VANDERWERF T
UIJEN GJH
REIBER JHC
BRUSCHKE AVG
STALENHOEF AFH
Citation: Aa. Kroon et al., LDL-APHERESIS ATHEROSCLEROSIS REGRESSION STUDY (LAARS) - EFFECT OF AGGRESSIVE VERSUS CONVENTIONAL LIPID-LOWERING TREATMENT ON CORONARY ATHEROSCLEROSIS, Circulation, 93(10), 1996, pp. 1826-1835
Citation: Aa. Kroon et al., EFFECT OF APHERESIS OF LOW-DENSITY-LIPOPROTEIN ON PERIPHERAL VASCULAR-DISEASE IN HYPERCHOLESTEROLEMIC PATIENTS WITH CORONARY-ARTERY DISEASE, Annals of internal medicine, 125(12), 1996, pp. 945
Authors:
KROON AA
AJUBI N
VANASTEN WNJC
STALENHOEF AFH
Citation: Aa. Kroon et al., THE PREVALENCE OF PERIPHERAL VASCULAR-DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, Journal of internal medicine, 238(5), 1995, pp. 451-459
Authors:
KNOPS RE
KROON AA
MOL MJTM
STUYT PMJ
STALENHOEF AFH
Citation: Re. Knops et al., LONG-TERM EXPERIENCE (6 YEARS) WITH SIMVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Netherlands journal of medicine, 46(4), 1995, pp. 171-178
Authors:
KROON AA
SWINKELS DW
VANDONGEN PWJ
STALENHOEF AFH
Citation: Aa. Kroon et al., PREGNANCY IN A PATIENT WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LONG-TERM LOW-DENSITY-LIPOPROTEIN APHERESIS, Metabolism, clinical and experimental, 43(9), 1994, pp. 1164-1170
Authors:
STALENHOEF AFH
LANSBERG PJ
KROON AA
KORTMANN B
DEHAAN AFJ
STUYT PMJ
KASTELEIN JJP
Citation: Afh. Stalenhoef et al., TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - SHORT-TERM EFFICACY AND SAFETY OF INCREASING DOSES OF SIMVASTATIN AND PRAVASTATIN - A DOUBLE-BLIND COMPARATIVE-STUDY, Journal of internal medicine, 234(1), 1993, pp. 77-82
Authors:
KROON AA
STALENHOEF AFH
BUIKEMA H
DEMACKER PNM
DEWILDE PCM
LEIJTEN PA
VANGILST WH
Citation: Aa. Kroon et al., THE EFFECT OF CHOLESTEROL REDUCTION ON THE ENDOTHELIAL FUNCTION AND PROGRESSION OF ATHEROSCLEROSIS IN WHHL RABBITS, Atherosclerosis, 103(2), 1993, pp. 221-230